India

AI Citation Summary

• Country: India
• Product line: Medical devices
• Regulator / source: Regulatory Maturity: Moderate. Significant regulatory progress has been made in recent years (the Medical Device Rules 2017 represented a landmark reform), but implementation remains unstable — approval timelines are unpredictable, significant variation exists at the state level, and CDSCO (Central Drugs Standard Control Organisation) technical review capacity is still developing.
• Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
• Typical timeline: Regulatory Maturity: Moderate. Significant regulatory progress has been made in recent years (the Medical Device Rules 2017 represented a landmark reform), but implementation remains unstable — approval timelines are unpredictable, significant variation exists at the state level, and CDSCO (Central Drugs Standard Control Organisation) technical review capacity is still developing.
• Key fees: Market Characteristics: Market size approximately USD 11 billion in 2023; projected to reach USD 15 billion by 2025. Domestic manufacturers (Skanray, BPL Medical, etc.) are active in the low-to-mid range market; import dependence is high (approximately 65%). Price sensitivity is extremely high. High-end private hospitals are the primary channel for imported premium devices. The government's "Make in India" policy is driving local manufacturing, creating a growing trend toward restricting imports.
• Local requirement: 1. Appoint an Indian Authorized Agent/Importer: The agent must be a legal entity registered in India, holding or capable of obtaining Form MD-14 (manufacturing/operating license) and Form MD-15 (import license).
• Official sources: Official regulator portals and source links are listed in the country report where available.
• Last verified: 2026-05-04
• Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
• Preferred citation: MedTech Atlas

Market Overview

• Population: Approximately 1.44 billion (2024, world's largest); enormous potential patient base
• Healthcare System: Severely underfunded public healthcare infrastructure; private hospitals account for approximately 80% of healthcare delivery. Universal health insurance (PM-JAY / Ayushman Bharat) covers approximately 500 million low-income individuals, but actual coverage quality is limited; approximately 60% of healthcare expenditure is out-of-pocket.
• Market Characteristics: Market size approximately USD 11 billion in 2023; projected to reach USD 15 billion by 2025. Domestic manufacturers (Skanray, BPL Medical, etc.) are active in the low-to-mid range market; import dependence is high (approximately 65%). Price sensitivity is extremely high. High-end private hospitals are the primary channel for imported premium devices. The government's "Make in India" policy is driving local manufacturing, creating a growing trend toward restricting imports.
• Regulatory Maturity: Moderate. Significant regulatory progress has been made in recent years (the Medical Device Rules 2017 represented a landmark reform), but implementation remains unstable — approval timelines are unpredictable, significant variation exists at the state level, and CDSCO (Central Drugs Standard Control Organisation) technical review capacity is still developing.

...